Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 26, 2023

BUY
$0.6 - $1.53 $38,536 - $98,268
64,228 Added 4.04%
1,652,650 $991,000
Q2 2023

Aug 10, 2023

BUY
$1.05 - $1.63 $188,591 - $292,765
179,611 Added 12.75%
1,588,422 $1.79 Million
Q1 2023

May 04, 2023

SELL
$1.2 - $2.73 $8,245 - $18,757
-6,871 Reduced 0.49%
1,408,811 $1.9 Million
Q4 2022

Feb 09, 2023

SELL
$1.71 - $3.61 $669,887 - $1.41 Million
-391,747 Reduced 21.67%
1,415,682 $2.63 Million
Q3 2022

Nov 10, 2022

BUY
$1.9 - $8.63 $158,292 - $718,982
83,312 Added 4.83%
1,807,429 $4.45 Million
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $1.67 Million - $7.05 Million
782,913 Added 83.18%
1,724,117 $4.21 Million
Q2 2022

Jul 26, 2022

BUY
$2.13 - $9.01 $293,390 - $1.24 Million
137,742 Added 17.14%
941,204 $2.3 Million
Q1 2022

May 10, 2022

SELL
$6.28 - $15.59 $1.15 Million - $2.85 Million
-182,531 Reduced 18.51%
803,462 $6.4 Million
Q4 2021

Feb 08, 2022

SELL
$14.7 - $28.67 $1.61 Million - $3.13 Million
-109,208 Reduced 9.97%
985,993 $15.1 Million
Q3 2021

Nov 15, 2021

SELL
$24.31 - $33.6 $1.92 Million - $2.65 Million
-78,867 Reduced 6.72%
1,095,201 $31.1 Million
Q2 2021

Aug 11, 2021

BUY
$26.09 - $40.4 $8.46 Million - $13.1 Million
324,380 Added 38.18%
1,174,068 $39.6 Million
Q1 2021

May 13, 2021

BUY
$33.06 - $56.93 $9.5 Million - $16.4 Million
287,351 Added 51.1%
849,688 $32.5 Million
Q4 2020

Feb 10, 2021

BUY
$39.09 - $57.4 $4.04 Million - $5.94 Million
103,470 Added 22.55%
562,337 $23.5 Million
Q3 2020

Nov 12, 2020

BUY
$28.43 - $44.67 $10.9 Million - $17.2 Million
384,872 Added 520.13%
458,867 $19.9 Million
Q2 2020

Aug 11, 2020

BUY
$11.71 - $30.29 $432,789 - $1.12 Million
36,959 Added 99.79%
73,995 $2.24 Million
Q1 2020

May 12, 2020

BUY
$7.64 - $27.5 $31,484 - $113,327
4,121 Added 12.52%
37,036 $506,000
Q4 2019

Feb 12, 2020

BUY
$15.02 - $20.57 $106,882 - $146,376
7,116 Added 27.58%
32,915 $531,000
Q3 2019

Nov 12, 2019

BUY
$18.85 - $27.5 $486,311 - $709,472
25,799 New
25,799 $497,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.